Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page’s informational footer revision was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering the study details shown on the record.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck and Small cell lung carcinoma to the study's listed conditions.SummaryDifference0.1%

- Check41 days agoChange DetectedHepatocellular Carcinoma was added to the conditions list, and the page revision was updated to v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page shows a routine version update from v3.4.2 to v3.4.3. No study content or data appears to have changed.SummaryDifference0.0%

- Check70 days agoChange DetectedGastric cancer has been added to the conditions section of the study page, including gastric/GEJ adenocarcinoma.SummaryDifference0.0%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.